ALB and glioma: Their study stated that DOX-loaded C/m-HSA NPs exhibited a linear gradual DOX release over 2 days (Fig. 17B), and a prominently 4-fold lower IC50 than plain NP and achieved over 85 % uptake in both brain endothelial and glioma cells.